Sofosbuvir‐based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection

2019 ◽  
Vol 34 (9) ◽  
pp. 1620-1625 ◽  
Author(s):  
Chen‐Hua Liu ◽  
Tung‐Hung Su ◽  
Chun‐Jen Liu ◽  
Chun‐Ming Hong ◽  
Hung‐Chih Yang ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Antiviral Therapies ◽  
Genotype 2 ◽  
Direct Acting

scholarly journals Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus

2018 ◽  
Vol 12 (3) ◽  
pp. 213-217
Author(s):  
Masako Okada ◽  
Hoang Hai ◽  
Akihiro Tamori ◽  
Sawako Uchida-Kobayashi ◽  
Masaru Enomoto ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Antiviral Treatment ◽  
Recombinant Hepatitis ◽  
Direct Acting Antiviral ◽  
Genotype 2 ◽  
Direct Acting

scholarly journals Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

Hepatology ◽  
2018 ◽  
Vol 67 (4) ◽  
pp. 1253-1260 ◽  
Author(s):  
Fred Poordad ◽  
Stanislas Pol ◽  
Armen Asatryan ◽  
Maria Buti ◽  
David Shaw ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Failure ◽  
Antiviral Treatment ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document